Cargando…
Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin
A 32 year old Asian female on 300 mg per day of phenytoin following meningioma excision developed a fever with a diffuse maculopapular rash, lymphadenopathy and splenomegaly after12 days. A diagnosis of DRESS (Drug Rash Eosinophilia and Systemic Symptoms) syndrome was made. Patient was started on pr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548378/ https://www.ncbi.nlm.nih.gov/pubmed/23349605 http://dx.doi.org/10.4103/0972-2327.104348 |
_version_ | 1782256318955913216 |
---|---|
author | Santhamoorthy, Ponnusamy Alexander, K John Alshubaili, Asmahan |
author_facet | Santhamoorthy, Ponnusamy Alexander, K John Alshubaili, Asmahan |
author_sort | Santhamoorthy, Ponnusamy |
collection | PubMed |
description | A 32 year old Asian female on 300 mg per day of phenytoin following meningioma excision developed a fever with a diffuse maculopapular rash, lymphadenopathy and splenomegaly after12 days. A diagnosis of DRESS (Drug Rash Eosinophilia and Systemic Symptoms) syndrome was made. Patient was started on prednisolone at a dose of 1 mg/kg but since there was further deterioration in her condition, intravenous immunoglobulin was started. Clinical and blood parameters began to improve by the next day with liver functions returning to normal by the third week. DRESS syndrome is a drug hypersensitivity syndrome which can be fatal and therefore needs to be recognized early for the appropriate treatment to be started. The use of Intravenous immunoglobulins is anecdotal and the dramatic improvement noted in this case indicates that it is another treatment choice. The case and a brief review of the literature are discussed. |
format | Online Article Text |
id | pubmed-3548378 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-35483782013-01-24 Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin Santhamoorthy, Ponnusamy Alexander, K John Alshubaili, Asmahan Ann Indian Acad Neurol Case Report A 32 year old Asian female on 300 mg per day of phenytoin following meningioma excision developed a fever with a diffuse maculopapular rash, lymphadenopathy and splenomegaly after12 days. A diagnosis of DRESS (Drug Rash Eosinophilia and Systemic Symptoms) syndrome was made. Patient was started on prednisolone at a dose of 1 mg/kg but since there was further deterioration in her condition, intravenous immunoglobulin was started. Clinical and blood parameters began to improve by the next day with liver functions returning to normal by the third week. DRESS syndrome is a drug hypersensitivity syndrome which can be fatal and therefore needs to be recognized early for the appropriate treatment to be started. The use of Intravenous immunoglobulins is anecdotal and the dramatic improvement noted in this case indicates that it is another treatment choice. The case and a brief review of the literature are discussed. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3548378/ /pubmed/23349605 http://dx.doi.org/10.4103/0972-2327.104348 Text en Copyright: © Annals of Indian Academy of Neurology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Santhamoorthy, Ponnusamy Alexander, K John Alshubaili, Asmahan Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin |
title | Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin |
title_full | Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin |
title_fullStr | Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin |
title_full_unstemmed | Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin |
title_short | Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin |
title_sort | intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548378/ https://www.ncbi.nlm.nih.gov/pubmed/23349605 http://dx.doi.org/10.4103/0972-2327.104348 |
work_keys_str_mv | AT santhamoorthyponnusamy intravenousimmunoglobulininthetreatmentofdrugrasheosinophiliaandsystemicsymptomscausedbyphenytoin AT alexanderkjohn intravenousimmunoglobulininthetreatmentofdrugrasheosinophiliaandsystemicsymptomscausedbyphenytoin AT alshubailiasmahan intravenousimmunoglobulininthetreatmentofdrugrasheosinophiliaandsystemicsymptomscausedbyphenytoin |